Site Alert

Claim & Account Center is currently experiencing intermittent slowdowns. We are working to resolve this problem as soon as possible. We apologize for any inconvenience.

News & Updates

News and updates for Medical Providers

Coverage decision on Selected Treatments for Varicose Veins. (October 31, 2017)
L&I has adopted a Health Technology Clinical Committee coverage decision on treatments for varicose veins. Effective on December 1, 2017, the selected treatments are covered benefits with conditions.


Coverage decision on Treatment of Chronic Migraine and Chronic Tension-type Headache. (October 31, 2017)
L&I has adopted a Health Technology Clinical Committee coverage decision on treatment of chronic migraine and chronic tension-type headache.  Effective on December 1, 2017, OnabotulinumtoxinA for treatment of chronic migraine is a covered benefit with conditions, however, OnabotulinumtoxinA is not covered for treatment of chronic tension-type headache.


Miss the Attending Doctors’ Handbook? (October 24, 2017)
It has been redesigned as an online Attending Provider Resource Center (version 1.0)!  You can find this under Provider Tools on the Medical Provider page of L&I’s website. This is only version 1.0; new sections and hyperlinks will be added as they become available. The sections are brief, providing only context explaining how the topics are relevant for attending providers, with hyperlinks that direct you to more detailed information. In this way, we can keep information current and not duplicate what is already elsewhere on L&I’s web site. There is even a hyperlink for you to provide us with direct feedback. And be sure to view the welcoming video by our Medical Director, Gary Franklin MD!


Surgical Guideline for Work-related Ankle and Foot Injuries. (August 9, 2017)
L&I has significantly expanded and updated the Ankle and Foot Guideline.  The updated Guideline is available on the Medical Treatment Guidelines webpage. The effective date is October 1, 2017.


Coverage decision on Sacral Nerve Stimulation for Fecal Incontinence. L&I has developed a coverage decision on Sacral Nerve Stimulation.  Effective on September 1, 2017, sacral nerve stimulation for fecal incontinence is a covered benefit with conditions.


Coverage decision on Extracorporeal Shock Wave Therapy (ESWT)
L&I has adopted the Health Technology Clinical Committee’s coverage determination to not cover Extracorporeal Shock Wave Therapy (ESWT) for musculoskeletal conditions. This coverage decision takes effect on August 1, 2017.


Carpal Tunnel Syndrome Guideline (May 26, 2017)
L&I has expanded the work-related portion of the Carpal Tunnel Syndrome (CTS) guideline related to computer use (mousing and keyboarding). The updated guideline is available within the Medical Treatment Guideline section and is effective July 1, 2017.


Coverage decision on Pharmacogenomic Testing (April 19, 2017)
L&I has adopted the Health Technology Clinical Committee’s coverage determination to not cover pharmacogenomic testing for selected psychiatric conditions.  In addition, L&I does not cover pharmacogenomic testing for any other condition. This coverage decision takes effect on July 1, 2017.


Coverage decision on Artificial Disc Replacement (ADR) (April 19, 2017)
L&I has adopted the Health Technology Clinical Committee’s coverage determination to not cover artificial disc replacement for degenerative disc disease (DDD); cervical ADR remains a covered benefit with conditions. This coverage decision is effective June 1, 2017.


Expanded Carpal Tunnel Syndrome Guideline – addresses computer use. (Feb. 21, 2017)
L&I has expanded the work-related portion of the Carpal Tunnel Syndrome (CTS) guideline related to computer use (mousing and keyboarding). Public comments are being accepted on the draft guideline through March 15, 2017. The draft guideline will be presented, along with all public comments, at the April 27th Industrial Insurance Medical Advisory Committee meeting.


Coverage decision on Fecal Microbiota Transplantation (Feb. 2, 2017)
L&I has adopted a Health Technology Clinical Committee coverage decision on fecal microbiota transplantation (FMT).  Effective on April 1, 2017, FMT is a covered benefit with conditions.


 

Archived News items

End of main content, page footer follows.

Access Washington official state portal

  © Washington State Dept. of Labor & Industries. Use of this site is subject to the laws of the state of Washington.

Help us improve